ABSTRACT
In the clinical investigation of a family with debilitating centrofacial pruritus by exome sequencing, we have observed a clear segregation of the TRPM3 variant outlined, which is highly suggestive of a causal relationship.
Subject(s)
Facial Dermatoses/genetics , Pruritus/genetics , TRPM Cation Channels/genetics , Female , Genes, Dominant , Genetic Variation , Humans , Middle Aged , Pedigree , Exome SequencingABSTRACT
Lupus miliaris disseminatus faciei (LMDF) is a chronic inflammatory dermatosis of unknown aetiology, most often seen in young adults. Although many treatments for LMDF exist, treatment guidelines have not been developed, and response to therapy is generally unpredictable. We present the results of transcriptomic analysis of LMDF lesional skin, which revealed a variety of differentially expressed genes linking LMDF to alterations in innate and adaptive T helper 1 immunity. Immunohistochemical analysis was also performed, identifying similar changes in T-cell immune responses. Given evidence for increased tumour necrosis factor (TNF) pathway activity, our patient, who had previously been refractory to multiple treatments, was initiated on TNF inhibitor therapy with excellent response. This characterization of the LMDF immune response may lead to improved treatment of this condition.
Subject(s)
Facial Dermatoses/immunology , Granuloma/drug therapy , Infliximab/therapeutic use , Rosacea/drug therapy , Tumor Necrosis Factor Inhibitors/therapeutic use , Administration, Intravenous , Chronic Disease , Drug Therapy, Combination/methods , Facial Dermatoses/genetics , Facial Dermatoses/pathology , Gene Expression Profiling/methods , Granuloma/diagnosis , Granuloma/immunology , Humans , Immunity, Cellular/immunology , Immunohistochemistry/methods , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/therapeutic use , Infliximab/administration & dosage , Male , Methotrexate/administration & dosage , Methotrexate/therapeutic use , Rosacea/diagnosis , Rosacea/immunology , T-Lymphocytes/immunology , Th1 Cells/immunology , Treatment Outcome , Tumor Necrosis Factor Inhibitors/administration & dosage , Young AdultABSTRACT
Variation in skin pigmentation can be affected by both environmental factors and intrinsic factors such as age, gender, and genetic variation. Recent GWASs revealed that genetic variants of genes functionally related to a pigmentation pathway were associated with skin pigmentary traits. However, these GWASs focused on populations with European ancestry, and only a few studies have been performed on Asian populations, limiting our understanding of the genetic basis of skin pigmentary traits in Asians. To evaluate the genetic variants associated with facial pigmented spots, we conducted a GWAS analysis of objectively measured facial pigmented spots in 17,019 Korean women. This large-scale GWAS identified several genomic loci that were significantly associated with facial pigmented spots (five previously reported loci and two previously unreported loci, to our knowledge), which were detected by UV light: BNC2 at 9p22 (rs16935073; P-value = 2.11 × 10-46), PPARGC1B at 5q32 (rs32579; P-value = 9.04 × 10-42), 10q26 (rs11198112; P-value = 9.66 × 10-38), MC1R at 16q24 (rs2228479; P-value = 6.62 × 10-21), lnc01877 at 2q33 (rs12693889; P-value = 1.59 × 10-11), CDKN2B-AS1 at 9p21 (rs643319; P-value = 7.76 × 10-9), and MFSD12 at 19p13 (rs2240751; P-value = 9.70 × 10-9). Further functional characterization of the candidate genes needs to be done to fully evaluate their contribution to facial pigmented spots.
Subject(s)
Asian People/genetics , Facial Dermatoses/genetics , Genetic Predisposition to Disease , Hyperpigmentation/genetics , Skin Pigmentation/genetics , Adult , Facial Dermatoses/epidemiology , Female , Genome-Wide Association Study , Humans , Hyperpigmentation/epidemiology , Middle Aged , Polymorphism, Single Nucleotide , Republic of Korea/epidemiologyABSTRACT
BACKGROUND: Atopic dermatitis (AD) is heterogenous in terms of phenotype as well as genetic and environmental factors, while its associated genetic factors and pathophysiology are not fully understood. OBJECTIVE: We identify novel genetic factors enriched in a subgroup of AD patients with characteristic clinical features. METHODS: We clinically subgrouped 18 AD patients who exhibited distinctive characteristic of persistent skin eruption areas on the face and neck from 92 Japanese adult AD patients and identified disease-associated genetic factors enriched within the subgroup. Targeted resequencing and subsequent genetic association analyses were used to identify novel enriched genetic variations in the subgroup compared with the other AD patients. RESULTS: Targeted resequencing of 648 skin associated genes revealed an enrichment of 12 single nucleotide variations (SNVs) in patients with face and neck AD (n = 18) compared with the general Japanese population in the database. Subsequent allele frequency comparison between the face and neck AD and non - face and neck AD subgroups revealed enrichment of five SNVs. Multivariate analysis using genotype data revealed that three SNVs in theTLR1, TIRAP, and PSAPL1 genes, two of the three genes are involved in the Toll-like receptor pathway, were significantly enriched in patients with face and neck AD. CONCLUSION: These findings revealed that the SNVs in genes associated with the innate immune pathway are enriched in a subgroup of AD. The combinational approach of clinical subgrouping and genotyping is valuable for detecting novel disease-associated genetic factors.
Subject(s)
Dermatitis, Atopic/genetics , Facial Dermatoses/genetics , Genetic Predisposition to Disease , Immunity, Innate/genetics , Adult , Aged , Dermatitis, Atopic/immunology , Facial Dermatoses/immunology , Female , Genotype , Humans , Japan , Male , Membrane Glycoproteins/genetics , Middle Aged , Neck , Polymorphism, Single Nucleotide , Receptors, Interleukin-1/genetics , Toll-Like Receptor 1/genetics , Young AdultSubject(s)
Facial Dermatoses/genetics , Histiocytosis, Langerhans-Cell/genetics , Myelodysplastic Syndromes/genetics , Cell Cycle Proteins/genetics , Facial Dermatoses/complications , Facial Dermatoses/pathology , High-Throughput Nucleotide Sequencing , Histiocytosis, Langerhans-Cell/complications , Histiocytosis, Langerhans-Cell/pathology , Humans , Isocitrate Dehydrogenase/genetics , Male , Middle Aged , Myelodysplastic Syndromes/complications , Repressor Proteins/genetics , Sequence Analysis, DNAABSTRACT
Background: The Trichophyton mentagrophytes complex is the second most common causal agent of dermatophytosis. It comprises five species-T. mentagrophytes, T. interdigitale, T. erinacei, T quinckeanum, and T. benhamie, as well as nine different genotypes of T. mentagrophytes / T. interdigitale-which are morphologically similar; however, their susceptibility to antifungal agents may differ. For targeted therapy and better prognosis, it is important to identify these species at a molecular level. However, since many hospitals lack molecular methods, the actual aetiology of dermatophytosis caused by this complex remains unknown. Objective: To characterize 55 anthropophilic isolates of the T. mentagrophytes complex recovered from a dermatological centre in Yucatán, Mexico. Material and methods: Fifty-five isolates of the T. mentagrophytes complex were obtained from patients with tinea capitis, tinea pedis, tinea corporis, tinea barbae, and tinea unguium. They were characterized by their colonial and microscopic morphology on Sabouraud dextrose agar (SDA) and through the sequencing of a fragment from the region ITS1-5.8S-ITS2. Results: All colonies grown on SDA were white. Forty-six isolates formed colonies with a powdery texture, while nine isolates formed colonies with a velvety texture. The micromorphological features were typical of the T. mentagrophytes complex. The molecular analysis revealed that 55 isolates were microorganisms that belonged to the T. mentagrophytes complex, that 46 formed powdery colonies representing T. mentagrophytes, and that the other nine isolates that formed velvety colonies represented T. interdigitale. The latter nine isolates were obtained from patients with tinea pedis, tinea corporis, and tinea unguium. Conclusions: The colony morphology on SDA led to the identification of 46 isolates as T. mentagrophytes and nine isolates as T. interdigitale. At a molecular level, the species identified by their morphology were identified only as T. mentagrophytes complex.
Subject(s)
Antifungal Agents/pharmacology , DNA, Intergenic/genetics , Tinea/genetics , Trichophyton/genetics , Facial Dermatoses/genetics , Facial Dermatoses/microbiology , Genotype , Humans , Onychomycosis/genetics , Onychomycosis/microbiology , Sequence Analysis, DNA , Tinea/microbiology , Tinea/pathology , Tinea Capitis/genetics , Tinea Capitis/microbiology , Tinea Pedis/genetics , Tinea Pedis/microbiology , Trichophyton/classification , Trichophyton/drug effects , Trichophyton/pathogenicityABSTRACT
BACKGROUND: Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein-Barr virus (EBV)-associated lymphoma that mainly affects children. OBJECTIVES: To examine the similarities and differences in the clinical pathological features, EBV infection status, and gene rearrangements in adults and children patients with HVLPD. METHODS: We compared the clinical manifestations, histopathology, immunophenotypical features, EBV infection status, and T-cell receptor gene rearrangements in the adult and children HVLPD groups. RESULTS: Clinical manifestations differed between children and adults groups. The children were characterized by blisters and severe facial swelling, whereas the adults were characterized by mild facial swelling and papules. Mosquito bite was significantly related to morbidity in the children group. Histologically, the number of mast cells in the adult group was greater than in the children group (P < 0.05). There were no significant differences in EBV infection status or TCR-γ gene rearrangements between 2 groups. CONCLUSIONS: There were differences in clinical pathology and prognosis between the 2 groups. A higher mast cell count and T-cell phenotype might be associated with a poor prognosis.
Subject(s)
Epstein-Barr Virus Infections/diagnosis , Facial Dermatoses/diagnosis , Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor , Genes, T-Cell Receptor gamma , Herpesvirus 4, Human/isolation & purification , Hydroa Vacciniforme/diagnosis , Lymphoma/diagnosis , Skin , Adolescent , Adult , Age Factors , Child , Epstein-Barr Virus Infections/genetics , Epstein-Barr Virus Infections/immunology , Epstein-Barr Virus Infections/virology , Facial Dermatoses/genetics , Facial Dermatoses/immunology , Facial Dermatoses/virology , Female , Genetic Markers , Genetic Predisposition to Disease , Humans , Hydroa Vacciniforme/genetics , Hydroa Vacciniforme/immunology , Hydroa Vacciniforme/virology , Immunohistochemistry , Immunophenotyping/methods , In Situ Hybridization, Fluorescence , Lymphoma/genetics , Lymphoma/immunology , Lymphoma/virology , Male , Mast Cells/immunology , Mast Cells/pathology , Mast Cells/virology , Middle Aged , Phenotype , Polymerase Chain Reaction , Retrospective Studies , Risk Factors , Skin/immunology , Skin/pathology , Skin/virology , Young AdultABSTRACT
BACKGROUND: Heterozygous mutations in caspase recruitment domain family member 14 gene (CARD14) have been shown to be associated with psoriasis and familial pityriasis rubra pilaris (PRP). Many subjects with CARD14 mutations display features of both disorders, which can result in diagnostic uncertainty. In addition, these eruptions are often recalcitrant to conventional psoriasis therapies such as methotrexate, oral retinoids, and tumor necrosis factor-α inhibitors. OBJECTIVE: We sought to describe the clinical characteristics, family history, and response to therapy in subjects with papulosquamous eruptions due to mutations in CARD14. METHODS: Subjects were referred for genetic testing as part of a registry of subjects with inherited disorders of keratinization. DNA was isolated from blood or saliva, and multiplex targeted sequencing or whole exome sequencing was performed. Clinical histories of subjects with CARD14 mutations were reviewed. RESULTS: We identified 15 kindreds with CARD14-associated papulosquamous eruption (CAPE). Characteristic features of CAPE include early age of onset; prominent involvement of the cheeks, chin, and ears; family history of psoriasis or PRP; minimal response to conventional topical and systemic psoriasis therapies; and improvement with ustekinumab. LIMITATIONS: Relatively small sample size. CONCLUSIONS: Many subjects with CARD14 mutations display characteristics of both psoriasis and PRP. We propose the term CARD14-associated papulosquamous eruption to describe this spectrum of disease. Subjects with clinical features suggestive of CAPE should undergo CARD14 sequencing and may benefit from treatment with ustekinumab.
Subject(s)
CARD Signaling Adaptor Proteins/genetics , Dermatologic Agents/therapeutic use , Facial Dermatoses/genetics , Guanylate Cyclase/genetics , Membrane Proteins/genetics , Skin Diseases, Papulosquamous/drug therapy , Skin Diseases, Papulosquamous/genetics , Ustekinumab/therapeutic use , Age of Onset , Child , Child, Preschool , Genetic Testing , Humans , Infant , Infant, Newborn , Phenotype , Pityriasis Rubra Pilaris/genetics , Psoriasis/genetics , Psoriasis/therapy , RetreatmentABSTRACT
GATA2 mutations have been identified in various diseases, such as MonoMAC syndrome, Emberger syndrome, familial myelodysplastic syndrome, acute myeloid leukaemia and dendritic cell, monocyte, B-cell and natural killer-cell deficiency. These syndromes present a wide range of clinical features, dominated by severe infections and haematological disorders such as myelodysplastic syndrome. Up to 70% of patients with GATA2 mutations have dermatological features, mainly genital or extragenital warts, panniculitis or erythema nodosum and lymphoedema. We report three patients presenting with common dermatological and haematological features leading to the diagnosis of GATA2 deficiency, but also with skin manifestations that have not been previously described: gingival hypertrophy, macroglossitis and glossitis and granulomatous lupoid facial lesions. Dermatologists can encounter patients with GATA2 mutations and should recognize this disorder.
Subject(s)
GATA2 Deficiency/complications , GATA2 Transcription Factor/genetics , Mutation/genetics , Skin Diseases/genetics , Adult , Child , Erythema Nodosum/genetics , Facial Dermatoses/genetics , Female , GATA2 Deficiency/diagnosis , Gingival Hypertrophy/genetics , Glossitis/genetics , Humans , Lupus Erythematosus, Cutaneous/genetics , Lymphedema/genetics , Male , Young AdultABSTRACT
BACKGROUND: Intrinsic and extrinsic factors, including ultraviolet irradiation, lead to visible signs of skin aging. OBJECTIVE: We evaluated molecular changes occurring in photoexposed and photoprotected skin of white women 20 to 74 years of age, some of whom appeared substantially younger than their chronologic age. METHODS: Histologic and transcriptomics profiling were conducted on skin biopsy samples of photoexposed (face and dorsal forearm) or photoprotected (buttocks) body sites from 158 women. 23andMe genotyping determined genetic ancestry. RESULTS: Gene expression and ontologic analysis revealed progressive changes from the 20s to the 70s in pathways related to oxidative stress, energy metabolism, senescence, and epidermal barrier; these changes were accelerated in the 60s and 70s. The gene expression patterns from the subset of women who were younger-appearing were similar to those in women who were actually younger. LIMITATIONS: Broader application of these findings (eg, across races and Fitzpatrick skin types) will require further studies. CONCLUSIONS: This study demonstrates a wide range of molecular processes in skin affected by aging, providing relevant targets for improving the condition of aging skin at different life stages and defining a molecular pattern of epidermal gene expression in women who appear younger than their chronologic age.
Subject(s)
Genetic Predisposition to Disease , Skin Aging/genetics , Skin Aging/physiology , Ultraviolet Rays/adverse effects , Adult , Aged , Aged, 80 and over , Biopsy, Needle , Facial Dermatoses/genetics , Facial Dermatoses/pathology , Female , Humans , Immunohistochemistry , Middle Aged , Prognosis , Risk Factors , Skin Aging/pathology , White People , Young AdultSubject(s)
Facial Dermatoses/genetics , Hair Diseases/complications , Hair Follicle/abnormalities , RecQ Helicases/genetics , Rothmund-Thomson Syndrome/complications , Rothmund-Thomson Syndrome/genetics , Facial Dermatoses/diagnosis , Frameshift Mutation , Humans , Infant , Male , Rothmund-Thomson Syndrome/diagnosisABSTRACT
Eruptive vellus hair cysts (EVHCs) often occur on the trunk and limbs. Facial involvement is uncommon. Autosomal dominant inheritance has been described, but associated extracutaneous anomalies have not. We describe a 4-patient kindred presenting with multiple facial EVHCs and an association of preauricular pits, lipomas, joint hypermobility, and cardiac defects. Histopathologic examination confirmed the diagnosis of EVHCs in 3 affected individuals. We propose that facial EVHCs may indicate the presence of an inherited autosomal dominant disorder with extracutaneous manifestations. Extracutaneous manifestations noted in the kindred have been sporadically described in association with steatocystoma multiplex (SM), a condition occasionally noted in the presence of EVHCs, further supporting an association between these disorders.
Subject(s)
Cysts/complications , Facial Dermatoses/complications , Hair Diseases/complications , Lipoma/complications , Child, Preschool , Craniofacial Abnormalities/complications , Craniofacial Abnormalities/genetics , Cysts/genetics , Cysts/pathology , Facial Dermatoses/genetics , Facial Dermatoses/pathology , Female , Hair Diseases/genetics , Hair Diseases/pathology , Heart Defects, Congenital/complications , Heart Defects, Congenital/genetics , Humans , Joint Instability/complications , Joint Instability/genetics , Lipoma/genetics , Male , PedigreeSubject(s)
Antineoplastic Agents/adverse effects , Indoles/adverse effects , Keratoacanthoma/chemically induced , Keratoacanthoma/genetics , Melanoma/drug therapy , Sarcoplasmic Reticulum Calcium-Transporting ATPases/genetics , Skin Neoplasms/drug therapy , Sulfonamides/adverse effects , Acantholysis/chemically induced , Acantholysis/pathology , Facial Dermatoses/chemically induced , Facial Dermatoses/genetics , Facial Dermatoses/pathology , Female , Gene Expression , Humans , Keratoacanthoma/pathology , Middle Aged , VemurafenibABSTRACT
Rosacea is a common chronic inflammatory skin disorder that typically occurs in adults and affects the face. Synonyms of rosacea include "acne rosacea", "couperose" and "facial erythrosis", in German also "Kupferfinne" and "Rotfinne". The disorder is characterised by a chronic and flaring course and is caused by a genetically predisposed, multifactorial process. A higher incidence is seen in people with fair skin and a positive family history. The characteristic rosacea symptoms manifest primarily, but not exclusively centrofacially, with forehead, nose, chin and cheeks significantly affected. Based on the various main symptoms a classification of the individual clinical pictures can be performed. However, a classification often does not reflect the clinical reality, since the various symptoms commonly coexist. The present review provides an introduction on pathogenesis and clinical manifestations of rosacea and prefers a symptom-oriented therapy approach.
Subject(s)
Facial Dermatoses/diagnosis , Facial Dermatoses/therapy , Patient-Centered Care/methods , Rosacea/diagnosis , Rosacea/therapy , Symptom Assessment/methods , Evidence-Based Medicine , Facial Dermatoses/genetics , Germany , Humans , Rosacea/genetics , Treatment OutcomeABSTRACT
Rosazea ist eine häufige chronisch-entzündliche Hauterkrankung, die typischerweise bei Erwachsenen vorkommt und das Gesicht betrifft. Synonyme der Rosazea sind Acne rosacea, Kupferfinne, Rotfinne, Couperose und Rosacea. Die Erkrankung ist durch einen chronischen und schubartigen Verlauf gekennzeichnet und wird durch ein genetisch prädisponiertes, multifaktorielles Geschehen bedingt. Ein vermehrtes Auftreten wird bei hellem Hauttyp und positiver Familienanamnese verzeichnet. Die charakteristischen Rosazea-Symptome manifestieren sich vorwiegend, aber nicht ausschließlich zentrofazial, wobei Stirn, Nase, Kinn und die Wangen maßgeblich betroffen sind. Dabei werden unterschiedliche Hauptsymptome voneinander unterschieden, anhand derer eine Klassifikation der verschiedenen klinischen Bilder vorgenommen werden kann. Eine Klassifizierung wird oftmals jedoch nicht der klinischen Realität gerecht, da die verschiedenen Symptome häufig gemeinsam auftreten. Diese Übersichtarbeit führt in die Pathogenese und Klinik der Rosazea ein und plädiert für einen symptomorientierten Therapieansatz.
Subject(s)
Facial Dermatoses/diagnosis , Facial Dermatoses/therapy , Patient-Centered Care/methods , Rosacea/diagnosis , Rosacea/therapy , Symptom Assessment/methods , Evidence-Based Medicine , Facial Dermatoses/genetics , Germany , Humans , Rosacea/genetics , Treatment OutcomeSubject(s)
Facial Dermatoses/genetics , Follicular Cyst/genetics , Pigmentation Disorders/genetics , Facial Dermatoses/surgery , Follicular Cyst/surgery , Humans , Laser Therapy/instrumentation , Lasers, Gas/therapeutic use , Male , Middle Aged , Pedigree , Pigmentation Disorders/surgery , Treatment Outcome , Young AdultABSTRACT
Although acne is almost universal in teenagers, few large cohort studies have investigated the profile of acne patients. To identify the profile of European patients with mild-to-moderate acne. an epidemiological study was performed using inclusion data from a prospective, international, observational phase IV study conducted in patients prescribed an anti-acne cream containing retinaldehyde, glycolic acid, modified rhamnose and Avene Thermal Spring Water. A total of 2926 patients (73.1% female) with mild to moderate acne (mean Global Evaluation of Acne score of 2.55 ± 0.7), aged 22.5 ± 8.0 years, were included in France, Switzerland, Italy and Portugal. A family history of acne was present in 62.9% of patients and mean age at acne onset was 16.0 ± 4.9 years. In total, 69.6% of patients had moderate to severe hyperseborrhoea, 35.6% acne lesions on both face and trunk, 23.6% facial pigmentation and 46% scars. The extent of acne was significantly associated with sex, age at acne onset, history of acne and presence of scars. In women, acne onset was delayed (p<0.0001) and a family history of acne and extension to the trunk were less common than in men (p = 0.0118, and p<0.0001), as were scars (p = 0.0042). In subjects with a family history of acne, the frequency in men was higher (p = 0.0118), acne onset was earlier (p<0.0001) and extension to the trunk and presence of scars were more common (both p<0.0001). Further epidemiological studies would help define specific risk factors for acne occurrence or progression, which may be modified.